Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Operating Margin: 2012-2025

Historic Operating Margin for Sunshine Biopharma (SBFM) over the last 12 years, with Sep 2025 value amounting to -11.54%.

  • Sunshine Biopharma's Operating Margin rose 158.00% to -11.54% in Q3 2025 from the same period last year, while for Sep 2025 it was -17.35%, marking a year-over-year decrease of 244.00%. This contributed to the annual value of -16.67% for FY2024, which is 320.00% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Operating Margin of -11.54% as of Q3 2025, which was up 47.15% from -21.83% recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Operating Margin peaked at -11.54% during Q3 2025, and registered a low of -3,184.50% during Q1 2021.
  • Its 3-year average for Operating Margin is -18.00%, with a median of -15.46% in 2023.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 284,493bps in 2021, then spiked by 218,701bps in 2022.
  • Quarterly analysis of 5 years shows Sunshine Biopharma's Operating Margin stood at -328.52% in 2021, then plummeted by 26,449bps to -593.01% in 2022, then spiked by 57,755bps to -15.46% in 2023, then plummeted by 578bps to -21.24% in 2024, then spiked by 158bps to -11.54% in 2025.
  • Its Operating Margin was -11.54% in Q3 2025, compared to -21.83% in Q2 2025 and -14.56% in Q1 2025.